Prolonged allograft survival following ex vivo blockade of costimulatory signals B7-1/2 and CD40. 2001

W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
Department of Transplant Surgery, D. Swarovski Research Laboratory, Innsbruck University Hospital, Innsbruck, Austria. wolfgang.steurer@uibk.ac.at

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D000069594 Abatacept A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS. BMS 188667,BMS-188667,BMS-224818,BMS224818,Belatacept,CTLA-4-Ig,CTLA4-Fc,CTLA4-Ig,CTLA4-Ig Immunoconjugate,Cytotoxic T Lymphocyte-Associated Antigen 4-Immunoglobulin,LEA29Y,Nulojix,Orencia,BMS 224818,BMS188667,CTLA4 Ig Immunoconjugate,Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin,Immunoconjugate, CTLA4-Ig
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation

Related Publications

W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
January 2019, Frontiers in immunology,
W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
January 1996, Immunologic research,
W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
December 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
March 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
January 2012, Transplant international : official journal of the European Society for Organ Transplantation,
W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
May 1995, Immunity,
W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
February 1998, Circulation,
W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
September 2002, Transplantation,
W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
June 1998, Transplantation proceedings,
W Steurer, and R Oellinger, and F Perwanger, and G Brandacher, and P Obrist, and G Klima, and R Margreiter
February 2015, Immunology and cell biology,
Copied contents to your clipboard!